glp-1 obesity drug news today september 2025 Agonists Market Report 2025-2033, By Product, Molecule, and Geo How to Invest in GLP-1
Description
2011;13(s1):11825
Longer-term liraglutide administration at the highest dose approved for obesity increases reward-related orbitofrontal cortex activation in response to food cues: Implications for plateauing weight loss in response to anti-obesity therapies
Something that works
P.WuQ.DuY.GurbuzS.et al (2023)
